A New Clinical Spectrum for the Assessment of Nonalcoholic Fatty Liver Disease Using Intelligent Methods
Nonalcoholic Fatty Liver Disease (NAFLD) is the most common cause of chronic liver disease around the world. Remaining silent in the early stages makes its evaluation a challenge. Liver biopsy is still the gold standard method used to classify NAFLD stages but has important sample error issues and s...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IEEE
2020-01-01
|
| Series: | IEEE Access |
| Subjects: | |
| Online Access: | https://ieeexplore.ieee.org/document/9146156/ |